Processa Pharmaceuticals, Inc. Debt Instrument, Increase, Accrued Interest
Processa Pharmaceuticals, Inc. (PCSA) reported Debt Instrument, Increase, Accrued Interest of $201 for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-14.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentIncreaseAccruedInterest · last filed 2018-08-14
- 2018-06-30: Debt Instrument, Increase, Accrued Interest 6 month $201.00.
- 2017-06-30: Debt Instrument, Increase, Accrued Interest 6 month $471.00.
| Period end | Debt Instrument, Increase, Accrued Interest 6 month |
|---|---|
| 2018-06-30 | $201.00 10-Q · filed 2018-08-14 |
| 2017-06-30 | $471.00 10-Q · filed 2018-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |